Efficacy and safety of combining intestinal stenting with laparoscopic surgery in colorectal cancer patients with acute intestinal obstruction

Table 1 Comparison of general data of two groups of patients, n (%)

Factors	Study group (n = 37)	Control group (n = 37)	P value
Age	50.67 ± 11.49	51.16 ± 10.58	0.869
Body weight (kg)	76.19 ± 8.48	75.02 ± 8.16	0.546
BMI (kg/m2)	26.13 ± 4.38	27.05 ± 5.15	0.369
Disease course (weeks)	3.13 ± 0.57	3.23 ± 0.52	0.653
Platelet (× 109/L)	228.17 ± 50.21	220.48 ± 57.07	0.682
Erythrocyte (× 109/L)	4.69 ± 0.67	4.75 ± 0.59	0.637
Leukocyte (× 109/L)	8.12 ± 1.19	7.91 ± 1.32	0.474
Sex			0.661
Male	27 (72.97)	31 (77.50)
Female	10 (27.03)	9 (22.50)
Smoking			0.768
Yes	25 (67.57)	29 (72.50)
No	12 (32.43)	11 (27.50)
Alcohol consumption			0.488
Yes	29 (78.38)	30 (75.00)
No	8 (21.62)	10 (25.00)
Exercise habit			0.717
Yes	4 (10.81)	3 (7.50)
No	33 (89.19)	37 (92.50)
Ethnicity			0.506
Han	35 (94.59)	37 (92.50)
Minority	2 (5.41)	3 (7.50)
Pathological stage			0.612
Stage I-II	17 (45.95)	22 (55.00)
Stage III-IV	20 (54.05)	18 (45.00)
Lymphatic metastasis			0.527
Yes	12 (32.43)	11 (27.50)
No	25 (67.57)	29 (72.50)
Intestinal obstruction degree			0.848
Complete	24 (64.86)	27 (67.50)
Incomplete	13 (35.14)	13 (32.50)
Primary tumor			0.879
Colon cancer	15 (40.54)	18 (45.00)
Rectal cancer	22 (59.46)	22 (55.00)
Histological type			0.974
Adenocarcinoma	14 (37.84)	15 (37.50)
Mucinous carcinoma	13 (35.14)	14 (35.00)
Undifferentiated carcinoma	10 (27.02)	9 (22.50)
Differentiation degree			0.875
Well-differentiated	20 (54.05)	19 (51.35)
Moderately differentiated	8 (21.62)	8 (21.62)
Poorly differentiated	9 (24.33)	10 (27.03)

BMI: Body mass index.

Table 2 Comparison of 12 months follow-up results, n (%)

Group	Control group (n = 37)	Study group (n = 37)	P value
Tumor recurrence rate	5 (13.51)	1 (2.70)	0.097
Overall survival rate	34 (91.89)	36 (97.30)	0.317